Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
4.280
-0.100 (-2.28%)
Jul 24, 2026, 2:55 PM EDT - Market open
Coya Therapeutics Market Cap
Coya Therapeutics has a market cap or net worth of $100.4 million as of July 24, 2026. Its market cap has decreased by -1.11% in one year.
Market Cap
100.40M
Enterprise Value
52.02M
1-Year Change
-1.11%
Ranking
Category
Stock Price
$4.28
ChartMarket Cap Chart
Since the IPO on December 29, 2022, Coya Therapeutics's market cap has increased from $11.84M to $100.40M, an increase of 748.14%. That is a compound annual growth rate of 82.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 100.40M | -17.27% |
| Dec 31, 2025 | 121.36M | 26.77% |
| Dec 31, 2024 | 95.73M | -10.29% |
| Dec 29, 2023 | 106.71M | 769.50% |
| Dec 30, 2022 | 12.27M | 3.68% |
| Dec 29, 2022 | 11.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anixa Biosciences | 121.12M |
| Fortress Biotech | 117.26M |
| Seer, Inc. | 115.46M |
| Polaryx Therapeutics | 109.84M |
| Black Diamond Therapeutics | 107.15M |
| Aldeyra Therapeutics | 105.56M |
| Oncolytics Biotech | 102.47M |
| ImmuCell | 101.28M |